ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,823Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 307

$527K Total Retail Price of All Prescriptions

Rank: 18 out of 307

251 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 251 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

26% of this provider’s 251 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,592 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 409 368 1 1
HYDROCODONE-ACETAMINOPHEN 360 291 S3 2 4
SIMVASTATIN 355 323 3 2
LISINOPRIL 286 264 4 3
OMEPRAZOLE 285 265 5 5
WARFARIN SODIUM 278 278 6 11
FUROSEMIDE 243 222 7 6
OXYCODONE HCL 232 132 S2 8 31
LOSARTAN POTASSIUM 190 179 9 16
AMLODIPINE BESYLATE 189 189 10 7
GABAPENTIN 176 140 11 15
METOPROLOL SUCCINATE 172 160 12 13
METFORMIN HCL 147 142 13 8
POTASSIUM CHLORIDE 137 130 14 10
CITALOPRAM HBR 137 130 14 14
LANTUS SOLOSTAR 104 82 16 72
FENTANYL 100 90 S2 17 35
CARVEDILOL 99 97 18 24
BUMETANIDE 92 92 19 125
ATORVASTATIN CALCIUM 90 84 20 18
METOPROLOL TARTRATE 88 76 21 12
ALENDRONATE SODIUM 87 76 22 20
CYMBALTA 86 62 23 30
MIRTAZAPINE 82 82 24 51
SPIRIVA 73 60 25 48
DOXAZOSIN MESYLATE 70 64 26 61
SPIRONOLACTONE 70 66 26 40
ADVAIR DISKUS 70 56 26 28
OXYCONTIN 68 44 S2 29 77
TAMSULOSIN HCL 67 65 30 21
TRAZODONE HCL 65 53 31 33
PANTOPRAZOLE SODIUM 62 49 32 49
NABUMETONE 58 44 33 102
COMBIVENT 57 57 34 90
ZOLPIDEM TARTRATE 56 50 35 19
CRESTOR 55 48 36 39
DILTIAZEM 24HR CD 54 54 37 143
LANTUS 54 48 37 47
OXYCODONE-ACETAMINOPHEN 53 52 S2 39 63
PROMETHAZINE HCL 52 33 R 40 115
SINGULAIR 52 31 40 100
KLOR-CON 10 51 51 42 95
HYDROCHLOROTHIAZIDE 50 50 43 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.